These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7905838)

  • 21. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ca(2+)-dependent 68-kilodalton protease in familial Alzheimer's disease cells cleaves the N-terminus of beta-amyloid.
    Matsumoto A; Fujiwara Y
    Biochemistry; 1994 Apr; 33(13):3941-8. PubMed ID: 8142398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
    Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pellicle precursor protein crosslinking characterization of an adduct between acidic proline-rich protein (PRP-1) and statherin generated by transglutaminase.
    Yao Y; Lamkin MS; Oppenheim FG
    J Dent Res; 2000 Apr; 79(4):930-8. PubMed ID: 10831095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.
    Schmid AW; Condemi E; Tuchscherer G; Chiappe D; Mutter M; Vogel H; Moniatte M; Tsybin YO
    J Biol Chem; 2011 Apr; 286(14):12172-88. PubMed ID: 21300794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase.
    Ho GJ; Gregory EJ; Smirnova IV; Zoubine MN; Festoff BW
    FEBS Lett; 1994 Jul; 349(1):151-4. PubMed ID: 7913896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced susceptibility to transglutaminase reaction of alpha-lactalbumin in the molten globule state.
    Matsumura Y; Chanyongvorakul Y; Kumazawa Y; Ohtsuka T; Mori T
    Biochim Biophys Acta; 1996 Jan; 1292(1):69-76. PubMed ID: 8547351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.
    Ghiso J; Rostagno A; Gardella JE; Liem L; Gorevic PD; Frangione B
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1053-9. PubMed ID: 1281980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.
    Fraser PE; McLachlan DR; Surewicz WK; Mizzen CA; Snow AD; Nguyen JT; Kirschner DA
    J Mol Biol; 1994 Nov; 244(1):64-73. PubMed ID: 7966323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro neurotoxicity of amyloid β-peptide cross-linked by transglutaminase.
    Shinagawa R; Masuda S; Sasaki R; Ikura K; Takahata K
    Cytotechnology; 1997 Jan; 23(1-3):77-85. PubMed ID: 22358523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.
    Knauer MF; Soreghan B; Burdick D; Kosmoski J; Glabe CG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7437-41. PubMed ID: 1502155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered processing characteristics of beta-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells.
    Matsumoto A
    Biochim Biophys Acta; 1994 Feb; 1225(3):304-10. PubMed ID: 8312378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
    Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
    Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular transglutaminases in neural development.
    Hand D; Perry MJ; Haynes LW
    Int J Dev Neurosci; 1993 Dec; 11(6):709-20. PubMed ID: 7907835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The amyloid peptide precursor in Alzheimer's disease.
    Octave JN
    Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of factor XIIIA-reactive glutamine acceptor and lysine donor sites within fibronectin-binding protein (FnbA) from Staphylococcus aureus.
    Anderson ET; Fletcher L; Severin A; Murphy E; Baker SM; Matsuka YV
    Biochemistry; 2004 Sep; 43(37):11842-52. PubMed ID: 15362870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.
    Parameswaran KN; Velasco PT; Wilson J; Lorand L
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8472-5. PubMed ID: 1978326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
    Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
    J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.
    Johnson TS; Griffin M; Thomas GL; Skill J; Cox A; Yang B; Nicholas B; Birckbichler PJ; Muchaneta-Kubara C; Meguid El Nahas A
    J Clin Invest; 1997 Jun; 99(12):2950-60. PubMed ID: 9185519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.